End-stage kidney disease due to alport syndrome: Outcomes in 296 consecutive Australia and New Zealand dialysis and transplant registry cases

Nephrology Dialysis Transplantation

Volumn 29, Issue 12, 2014, Pages 2277-2286

  Mallett, Andrew ^a,b,c   Tang, Wen ^d   Clayton, Philip A ^a,e,f   Stevenson, Sarah ^a,b   McDonald, Stephen P ^a,g   Hawley, Carmel M ^a,b   Badve, Sunil V ^a,b   Boudville, Neil ^a,h   Brown, Fiona G ^a,i   Campbell, Scott B ^a,b   Johnson, David W ^a,b  

^a ANZDATA Registry   (Australia)

^b PRINCESS ALEXANDRA HOSPITAL   (Australia)

^c ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^d PEKING UNIVERSITY THIRD HOSPITAL   (China)

^e ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^f UNIVERSITY OF SYDNEY   (Australia)

^g UNIVERSITY OF ADELAIDE   (Australia)

^h UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

ⁱ MONASH MEDICAL CENTRE   (Australia)

Author keywords

Alport syndrome; Dialysis; Hereditary nephritis; Outcomes; Renal transplantation

Indexed keywords

ADOLESCENT; ADULT; AGED; ALPORT SYNDROME; ARTICLE; AUSTRALIA; CAUSE OF DEATH; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; END STAGE RENAL DISEASE; FEMALE; GRAFT FAILURE; GRAFT SURVIVAL; HEMODIALYSIS; HUMAN; KIDNEY ALLOGRAFT; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY RATE; NEW ZEALAND; PERITONEAL DIALYSIS; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; SURVIVAL RATE; VERY ELDERLY; CLINICAL TRIAL; COMPLICATION; FOLLOW UP; INCIDENCE; INFANT; KIDNEY FAILURE, CHRONIC; MIDDLE AGED; MULTICENTER STUDY; NEPHRITIS, HEREDITARY; NEWBORN; PRESCHOOL CHILD; PROGNOSIS; REGISTER; RETROSPECTIVE STUDY; TRENDS; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AUSTRALIA; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; GRAFT SURVIVAL; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; NEPHRITIS, HEREDITARY; NEW ZEALAND; PROGNOSIS; REGISTRIES; RETROSPECTIVE STUDIES; SURVIVAL RATE; YOUNG ADULT;

EID: 84928702109     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfu254     Document Type: Article

References (56)

1. Levy M, Feingold J. Estimating prevalence in single-gene kidney diseases progressing to renal failure. Kidney Int 2000; 58: 925-943
2. Hasstedt SJ, Atkin CL. X-linked inheritance of Alport syndrome: family P revisited. Am J Hum Genet 1983; 35: 1241-1251
3. Alport AC. Hereditary familial congenital haemorrhagic nephritis. Br Med J 1927; 1: 504-506
4. Grunfeld JP. The clinical spectrum of hereditary nephritis. Kidney Int 1985; 27: 83-92
5. Savige J, Colville D. Opinion: ocular features aid the diagnosis of Alport syndrome. Nat Rev Nephrol 2009; 5: 356-360
6. Savige J, Ratnaike S, Colville D. Retinal abnormalities characteristic of inherited renal disease. J Am Soc Nephrol 2011; 22: 1403-1415
7. Kashtan CE, Segal Y, Flinter F et al. Aortic abnormalities in males with Alport syndrome. Nephrol Dial Transplant 2010; 25: 3554-3560
8. Antignac C. Molecular genetics of basement membranes: the paradigm of Alport syndrome. Kidney Int Suppl 1995; 49: S29-S33
9. Lemmink HH, Schroder CH, Monnens LA et al. The clinical spectrum of type IV collagen mutations. Hum Mutat 1997; 9: 477-499
10. Savige J. Hereditary abnormalities of renal basement membranes. Pathology 1991; 23: 350-355
11. Mochizuki T, Lemmink HH, Mariyama M et al. Identification of mutations in the alpha 3(IV) and alpha 4(IV) collagen genes in autosomal recessive Alport syndrome. Nat Genet 1994; 8: 77-81
12. Longo I, Porcedda P, Mari F et al. COL4A3/COL4A4 mutations: from familial hematuria to autosomal-dominant or recessive Alport syndrome. Kidney Int 2002; 61: 1947-1956
13. Pescucci C, Mari F, Longo I et al. Autosomal-dominant Alport syndrome: natural history of a disease due to COL4A3 or COL4A4 gene. Kidney Int 2004; 65: 1598-1603
14. Rheault MN, Kren SM, Thielen BK et al. Mouse model of X-linked Alport syndrome. J Am Soc Nephrol 2004; 15: 1466-1474
15. Barker DF, Hostikka SL, Zhou J et al. Identification of mutations in the COL4A5 collagen gene in Alport syndrome. Science 1990; 248: 1224-1227
16. Flinter FA, Cameron JS, Chantler C et al. Genetics of classic Alport's syndrome. Lancet 1988; 2: 1005-1007
17. Flinter FA, Abbs S, Bobrow M. Localization of the gene for classic Alport syndrome. Genomics 1989; 4: 335-338
18. Arrondel C, Deschenes G, Le Meur Y et al. A large tandem duplication within the COL4A5 gene is responsible for the high prevalence of Alport syndrome in French Polynesia. Kidney Int 2004; 65: 2030-2040
19. Feingold J, Bois E, Chompret A et al. Genetic heterogeneity of Alport syndrome. Kidney Int 1985; 27: 672-677
20. Temme J, Kramer A, Jager KJ et al. Outcomes of male patients with Alport syndrome undergoing renal replacement therapy. Clin J Am Soc Nephrol 2012; 7: 1969-1976
21. Jais JP, Knebelmann B, Giatras I et al. X-linked Alport syndrome: natural history in 195 families and genotype-phenotype correlations in males. J Am Soc Nephrol 2000; 11: 649-657
22. Jais JP, Knebelmann B, Giatras I et al. X-linked Alport syndrome: natural history and genotype-phenotype correlations in girls and women belonging to 195 families: a 'European Community Alport Syndrome Concerted Action' study. J Am Soc Nephrol 2003; 14: 2603-2610
23. Rheault MN, Kren SM, Hartich LA et al. X-inactivation modifies disease severity in female carriers of murine X-linked Alport syndrome. Nephrol Dial Transplant 2010; 25: 764-769
24. McCoy RC, Johnson HK, Stone WJ et al. Absence of nephritogenic GBM antigen(s) in some patients with hereditary nephritis. Kidney Int 1982; 21: 642-652
25. Hudson BG, Kalluri R, Gunwar S et al. The pathogenesis of Alport syndrome involves type IV collagen molecules containing the alpha 3(IV) chain: evidence from anti-GBM nephritis after renal transplantation. Kidney Int 1992; 42: 179-187
26. Wang XP, Fogo AB, Colon S et al. Distinct epitopes for anti-glomerular basement membrane alport alloantibodies and goodpasture autoantibodies within the noncollagenous domain of alpha3(IV) collagen: a janusfaced antigen. J Am Soc Nephrol 2005; 16: 3563-3571
27. Kalluri R, van den Heuvel LP, Smeets HJ et al. A COL4A3 gene mutation and post-transplant anti-alpha 3(IV) collagen alloantibodies in Alport syndrome. Kidney Int 1995; 47: 1199-1204
28. Kalluri R, Weber M, Netzer KO et al. COL4A5 gene deletion and production of post-transplant anti-alpha 3(IV) collagen alloantibodies in Alport syndrome. Kidney Int 1994; 45: 721-726
29. Gretz N, Broyer M, Brunner FP et al. Alport's syndrome as a cause of renal failure in Europe. Pediatr Nephrol 1987; 1: 411-415
30. Berardinelli L, Pozzoli E, Raiteri M et al. Renal transplantation in Alport's syndrome. Personal experience in twelve patients. Contrib Nephrol 1990; 80: 131-134
31. Peten E, Pirson Y, Cosyns JP et al. Outcome of thirty patients with Alport's syndrome after renal transplantation. Transplantation 1991; 52: 823-826
32. Gobel J, Olbricht CJ, Offner G et al. Kidney transplantation in Alport's syndrome: long-term outcome and allograft anti-GBM nephritis. Clin Nephrol 1992; 38: 299-304
33. Byrne MC, Budisavljevic MN, Fan Z et al. Renal transplant in patients with Alport's syndrome. Am J Kidney Dis 2002; 39: 769-775
34. Kashtan CE. Renal transplantation in patients with Alport syndrome. Pediatr Transplant 2006; 10: 651-657
35. Mojahedi MJ, Hekmat R, Ahmadnia H. Kidney transplantation in patients with alport syndrome. Urol J 2007; 4: 234-237
36. Gumber MR, Kute VB, Goplani KR et al. Outcome of renal transplantation in Alport's syndrome: a single-center experience. Transplant Proc 2012; 44: 261-263
37. Barocci S, Fiordoro S, Santori G et al. Alport syndrome: HLA association and kidney graft outcome. Eur J Immunogenet 2004; 31: 115-119
38. Karakayali H, Pehlivan S, Ekici Y et al. Acute rejection rates and survival of renal transplant recipients with Alport's Syndrome. Transplant Proc 2008; 40: 120-122
39. Ahmed A, Rich MW, Sanders PW et al. Chronic kidney disease associated mortality in diastolic versus systolic heart failure: a propensity matched study. Am J Cardiol 2007; 99: 393-398
40. Lunn M, McNeil D. Applying Cox regression to competing risks. Biometrics 1995; 51: 524-532
41. Kashtan CE. Alport syndrome and thin basement membrane nephropathy. In: Pagon RA, Bird TD, Dolan CR et al. (eds). GeneReviews. Seattle, WA: University ofWashington, 1993
42. Savige J, Gregory M, Gross O et al. Expert guidelines for the management of Alport syndrome and thin basement membrane nephropathy. J Am Soc Nephrol 2013; 24: 364-375
43. Kashtan CE, Ding J, Gregory M et al. Clinical practice recommendations for the treatment of Alport syndrome: a statement of the Alport Syndrome Research Collaborative. Pediatr Nephrol 2013; 28: 5-11
44. Temme J, Peters F, Lange K et al. Incidence of renal failure and nephroprotection by RAAS inhibition in heterozygous carriers of Xchromosomal and autosomal recessive Alport mutations. Kidney Int 2012; 81: 779-783
45. Webb NJ, Lam C, Shahinfar S et al. Efficacy and safety of losartan in children with Alport syndrome-results from a subgroup analysis of a prospective, randomized, placebo-or amlodipine-controlled trial. Nephrol Dial Transplant 2011; 26: 2521-2526
46. Proesmans W, Van Dyck M. Enalapril in children with Alport syndrome. Pediatr Nephrol 2004; 19: 271-275
47. Gross O, Licht C, Anders HJ et al. Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy. Kidney Int 2012; 81: 494-501
48. Gross O, Friede T, Hilgers R et al. Safety and efficacy of the ACE-inhibitor Ramipril in Alport syndrome: the double-blind, randomized, placebocontrolled, multicenter phase III EARLY PRO-TECT Alport Trial in Pediatric Patients. ISRN Pediatr 2012; 2012: 436046
49. Shah B, First MR, Mendoza NC et al. Alport's syndrome: risk of glomerulonephritis induced by anti-glomerular-basement-membrane antibody after renal transplantation. Nephron 1988; 50: 34-38
50. Ding J, Zhou J, Tryggvason K et al. COL4A5 deletions in three patients with Alport syndrome and posttransplant antiglomerular basement membrane nephritis. J Am Soc Nephrol 1994; 5: 161-168
51. Brosens I, Pijnenborg R, Benagiano G. Risk of obstetrical complications in organ transplant recipient pregnancies. Transplantation 2013; 96: 227-233
52. Armenti VT, Constantinescu S, Moritz MJ et al. Pregnancy after transplantation. Transplant Rev (Orlando) 2008; 22: 223-240
53. Bramham K, Nelson-Piercy C, Gao H et al. Pregnancy in renal transplant recipients: a UK national cohort study. Clin J Am Soc Nephrol 2013; 8: 290-298
54. Coscia LA, Constantinescu S, Moritz MJ et al. Report from the National Transplantation Pregnancy Registry (NTPR): outcomes of pregnancy after transplantation. Clin Transpl 2010; 26: 65-85
55. Luders C, Castro MC, Titan SM et al. Obstetric outcome in pregnant women on long-term dialysis: a case series. Am J Kidney Dis 2010; 56: 77-85
56. Furaz-Czerpak KR, Fernandez-Juarez G, Moreno-de la Higuera MA et al. Pregnancy in women on chronic dialysis: a review. Nefrologia 2012; 32: 287-294